Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2023-02-03 00:00:00 ET · period of report 2023-02-01 · accession 0001765581-23-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-03 | 2023-02-01 | JAZZ | COZADD BRUCE C | COB, CEO, Dir | S - Sale | $155.79 | -1,000 | 367.1K | -0.3% | -$155.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2023-02-01 | S | D | 1,000 | $155.79 | 367,078 | D | — | — |